Titan Non Currrent Assets Other vs Net Debt Analysis

TTNP Stock  USD 3.88  0.08  2.02%   
Titan Pharmaceuticals financial indicator trend analysis is much more than just breaking down Titan Pharmaceuticals prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Titan Pharmaceuticals is a good investment. Please check the relationship between Titan Pharmaceuticals Non Currrent Assets Other and its Net Debt accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Titan Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
To learn how to invest in Titan Stock, please use our How to Invest in Titan Pharmaceuticals guide.

Non Currrent Assets Other vs Net Debt

Non Currrent Assets Other vs Net Debt Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Titan Pharmaceuticals Non Currrent Assets Other account and Net Debt. At this time, the significance of the direction appears to have almost no relationship.
The correlation between Titan Pharmaceuticals' Non Currrent Assets Other and Net Debt is 0.16. Overlapping area represents the amount of variation of Non Currrent Assets Other that can explain the historical movement of Net Debt in the same time period over historical financial statements of Titan Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Titan Pharmaceuticals' Non Currrent Assets Other and Net Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Currrent Assets Other of Titan Pharmaceuticals are associated (or correlated) with its Net Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Debt has no effect on the direction of Non Currrent Assets Other i.e., Titan Pharmaceuticals' Non Currrent Assets Other and Net Debt go up and down completely randomly.

Correlation Coefficient

0.16
Relationship DirectionPositive 
Relationship StrengthInsignificant

Non Currrent Assets Other

Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.

Net Debt

The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.
Most indicators from Titan Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Titan Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Titan Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
To learn how to invest in Titan Stock, please use our How to Invest in Titan Pharmaceuticals guide.As of 12/04/2024, Sales General And Administrative To Revenue is likely to grow to 52.45, while Selling General Administrative is likely to drop slightly above 5.4 M.

Titan Pharmaceuticals fundamental ratios Correlations

0.59-0.30.71-0.110.69-0.64-0.020.740.950.08-0.350.970.85-0.470.45-0.560.590.990.32-0.350.090.70.66-0.330.68
0.59-0.340.68-0.650.430.170.470.730.430.33-0.170.460.66-0.750.79-0.860.820.540.680.15-0.330.730.780.130.12
-0.3-0.34-0.180.20.10.120.11-0.42-0.350.280.11-0.32-0.47-0.16-0.350.32-0.32-0.34-0.220.30.09-0.47-0.440.27-0.14
0.710.68-0.18-0.620.65-0.110.30.540.620.42-0.210.640.58-0.490.66-0.580.850.650.440.10.160.480.520.090.55
-0.11-0.650.2-0.62-0.03-0.61-0.28-0.25-0.01-0.170.31-0.03-0.180.3-0.90.32-0.87-0.09-0.22-0.230.16-0.15-0.19-0.190.15
0.690.430.10.65-0.03-0.40.230.590.520.53-0.10.570.54-0.70.15-0.490.360.610.340.010.360.450.460.00.8
-0.640.170.12-0.11-0.61-0.40.39-0.32-0.730.20.16-0.72-0.48-0.110.310.060.17-0.670.050.55-0.35-0.36-0.280.49-0.66
-0.020.470.110.3-0.280.230.390.12-0.190.90.67-0.170.02-0.530.11-0.580.2-0.150.810.91-0.240.10.270.92-0.11
0.740.73-0.420.54-0.250.59-0.320.120.580.11-0.380.610.93-0.580.52-0.730.570.730.47-0.26-0.020.80.79-0.240.44
0.950.43-0.350.62-0.010.52-0.73-0.190.58-0.1-0.360.990.75-0.240.36-0.420.490.970.2-0.470.10.640.58-0.440.64
0.080.330.280.42-0.170.530.20.90.11-0.10.6-0.070.02-0.57-0.01-0.460.16-0.060.660.850.080.010.170.850.21
-0.35-0.170.11-0.210.31-0.10.160.67-0.38-0.360.6-0.36-0.410.02-0.51-0.11-0.44-0.430.450.75-0.04-0.24-0.10.77-0.24
0.970.46-0.320.64-0.030.57-0.72-0.170.610.99-0.07-0.360.75-0.290.37-0.450.510.980.22-0.450.110.660.6-0.430.64
0.850.66-0.470.58-0.180.54-0.480.020.930.750.02-0.410.75-0.430.49-0.630.570.850.4-0.34-0.050.760.72-0.310.55
-0.47-0.75-0.16-0.490.3-0.7-0.11-0.53-0.58-0.24-0.570.02-0.29-0.43-0.390.73-0.47-0.38-0.59-0.270.26-0.53-0.6-0.24-0.22
0.450.79-0.350.66-0.90.150.310.110.520.36-0.01-0.510.370.49-0.39-0.440.950.450.21-0.07-0.210.410.4-0.10.0
-0.56-0.860.32-0.580.32-0.490.06-0.58-0.73-0.42-0.46-0.11-0.45-0.630.73-0.44-0.53-0.49-0.9-0.220.23-0.86-0.94-0.24-0.18
0.590.82-0.320.85-0.870.360.170.20.570.490.16-0.440.510.57-0.470.95-0.530.570.32-0.01-0.080.480.48-0.030.22
0.990.54-0.340.65-0.090.61-0.67-0.150.730.97-0.06-0.430.980.85-0.380.45-0.490.570.23-0.470.070.70.64-0.450.65
0.320.68-0.220.44-0.220.340.050.810.470.20.660.450.220.4-0.590.21-0.90.320.230.54-0.290.620.750.580.07
-0.350.150.30.1-0.230.010.550.91-0.26-0.470.850.75-0.45-0.34-0.27-0.07-0.22-0.01-0.470.54-0.15-0.29-0.111.0-0.27
0.09-0.330.090.160.160.36-0.35-0.24-0.020.10.08-0.040.11-0.050.26-0.210.23-0.080.07-0.29-0.15-0.14-0.17-0.150.46
0.70.73-0.470.48-0.150.45-0.360.10.80.640.01-0.240.660.76-0.530.41-0.860.480.70.62-0.29-0.140.98-0.260.3
0.660.78-0.440.52-0.190.46-0.280.270.790.580.17-0.10.60.72-0.60.4-0.940.480.640.75-0.11-0.170.98-0.080.26
-0.330.130.270.09-0.190.00.490.92-0.24-0.440.850.77-0.43-0.31-0.24-0.1-0.24-0.03-0.450.581.0-0.15-0.26-0.08-0.24
0.680.12-0.140.550.150.8-0.66-0.110.440.640.21-0.240.640.55-0.220.0-0.180.220.650.07-0.270.460.30.26-0.24
Click cells to compare fundamentals

Titan Pharmaceuticals Account Relationship Matchups

Titan Pharmaceuticals fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets9.5M8.1M8.0M4.1M8.1M7.7M
Short Long Term Debt Total4.4M809K299K187K565K536.8K
Other Current Liab1.9M2.3M1.4M1.5M519K493.1K
Total Current Liabilities3.6M4.2M2.7M2.6M1.4M1.4M
Total Stockholder Equity1.4M3.5M5.1M1.4M6.6M6.3M
Property Plant And Equipment Net1.2M759K717K407K68K64.6K
Net Debt(782K)(4.6M)(5.7M)(2.8M)(6.2M)(6.5M)
Retained Earnings(349.0M)(367.3M)(376.1M)(386.3M)(391.8M)(372.2M)
Accounts Payable1.4M1.3M795K695K348K330.6K
Cash5.2M5.4M6.0M2.9M6.8M8.3M
Non Current Assets Total1.2M759K765K455K68K64.6K
Non Currrent Assets Other794K(1.2M)(759K)48K(1.0)(0.95)
Cash And Short Term Investments5.2M5.4M6.0M2.9M6.8M6.4M
Net Receivables993K884K112K36K1.0M1.6M
Common Stock Shares Outstanding1.3K188.7K486.5K671.7K752K789.6K
Liabilities And Stockholders Equity9.5M8.1M8.0M4.1M8.1M7.7M
Non Current Liabilities Total3.8M4.5M332K187K65K0.0
Other Stockholder Equity350.4M370.8M381.2M387.6M398.5M418.4M
Total Liab8.1M4.6M2.9M2.7M1.4M1.4M
Total Current Assets8.3M7.3M7.2M3.6M8.0M7.6M
Short Term Debt272K627K224K244K565K1.1M
Other Current Assets1.1M703K787K524K199K189.1K
Property Plant And Equipment Gross1.2M618K2.1M2M774K883.3K
Common Stock57K7K10K15K1K950.0
Property Plant Equipment794K1.2M759K717K824.6K826.4K
Long Term Debt3.6M3.8M4.0M332K298.8K283.9K
Retained Earnings Total Equity(323.3M)(332.6M)(349.0M)(367.3M)(330.6M)(347.1M)
Net Tangible Assets6.8M1.4M3.5M5.1M4.6M4.7M
Capital Surpluse26.3M339.4M350.4M370.8M426.4M447.7M
Net Invested Capital5.5M4.2M5.1M1.4M7.1M4.8M

Pair Trading with Titan Pharmaceuticals

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Titan Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Titan Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.

Moving against Titan Stock

  0.89ETON Eton Pharmaceuticals Potential GrowthPairCorr
  0.88VRNA Verona Pharma PLCPairCorr
  0.82EWTX Edgewise TherapeuticsPairCorr
  0.81ELDN Eledon PharmaceuticalsPairCorr
  0.46DSGN Design TherapeuticsPairCorr
The ability to find closely correlated positions to Titan Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Titan Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Titan Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Titan Pharmaceuticals to buy it.
The correlation of Titan Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Titan Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Titan Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Titan Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Titan Stock Analysis

When running Titan Pharmaceuticals' price analysis, check to measure Titan Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Titan Pharmaceuticals is operating at the current time. Most of Titan Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Titan Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Titan Pharmaceuticals' price. Additionally, you may evaluate how the addition of Titan Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.